haemophilus influenzae type b conjugate vaccine (HibTITER) Report issue

Vaccine Approved FDA
AACT MeSH

Active Ingredient History

NOW
  • Now
The Haemophilus influenzae type B vaccine, also known as Hib vaccine, is a vaccine used to prevent Haemophilus influenzae type b (Hib) infection. In countries that include it as a routine vaccine, rates of severe Hib infections have decreased more than 90%. It has therefore resulted in a decrease in the rate of meningitis, pneumonia, and epiglottitis.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Drug Pricing (per unit)

United States

$18.7310 - $25.0760
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

a+c+hib conjugate vaccine | acthib | act-hib | combact-hib | dpo 20 vaccine | gsk208108 | haemophilus b conjugate vaccine | haemophilus b conjugate vaccine (meningococcal protein conjugate) | haemophilus b conjugate vaccine (tetanus toxoid conjugate) | haemophilus influenzae b oligosaccharide vaccine-diphtheria toxoid conjugate | haemophilus influenzae type b conjugate vaccine | haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate | haemophilus influenzae type b vaccine | haemophilus influenzae type b vaccine, pure polysaccharide | haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate | hib capsular polysaccharide-tetanus vaccine | hib conjugate vaccine | hib cps-tetanus vaccine | hib-crm197 | hiberix | hibest | hib-ps-diphtheria toxoid conjugate vaccine | hib-ps-dt vaccine | hib-tt | hib vaccine | hib-vax | infanrix-ipv/hib | lbvh0101 | minhai-hib | omnihib | prohibit | prp antigen | prp-d | prp-t | tetanus toxoid polysaccharide-conjugated vaccine against haemophilus influenzae type b | type b haemophilus influenza conjugate vaccine | vaxem hib | zilbrix

Organizations (48)

Research & Development (48)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (47)

Approved Indications (1)


 

Haemophilus Vaccines (approved 1987)

Experimental Indications - Clinical Trial Phases 1-4 (46)


 

Bacterial Infections (Phase 3)

Carrier State (Phase 4)

Communicable Diseases (Phase 2)

Dengue (Phase 3)

Diphtheria (Phase 4)

Diphtheria-Tetanus-Pertussis Vaccine (Phase 3)

Diphtheria Toxoid (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

Dysentery (Phase 2)

Dysentery, Bacillary (Phase 2)

Haemophilus Infections (Phase 4)

Haemophilus influenzae (Phase 4)

Haemophilus influenzae type b (Phase 4)

Healthy Volunteers (Phase 4)

Hepatitis A (Phase 3)

Hepatitis B (Phase 4)

Hospitalization (Phase 4)

Immune System Diseases (Phase 4)

Immunization (Phase 3)

Influenza B virus (Phase 3)

Influenza, Human (Phase 3)

Malaria (Phase 2)

Meninges (Phase 2)

Meningitis (Phase 4)

Meningitis, Bacterial (Phase 3)

Meningitis, Meningococcal (Phase 3)

Meningococcal Infections (Phase 4)

Mortality (Phase 4)

Neisseria meningitidis (Phase 3)

Pertussis Vaccine (Phase 4)

Pneumococcal Infections (Phase 3)

Pneumococcal Vaccines (Phase 3)

Pneumonia, Pneumococcal (Phase 1/Phase 2)

Pneumonia, Staphylococcal (Phase 3)

Poliomyelitis (Phase 4)

Poliovirus Vaccines (Phase 2)

Rotavirus Infections (Phase 3)

Rotavirus Vaccines (Phase 3)

Severe Dengue (Phase 3)

Streptococcal Infections (Phase 4)

Streptococcus pneumoniae (Phase 3)

Tetanus (Phase 4)

Typhoid Fever (Phase 2)

Virus Diseases (Phase 3)

Whooping Cough (Phase 4)

Yellow Fever (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 121
  • # of Trial Organizations: 48

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue